Wall Street stayed hot this week, with AI giants, energy disrupters, and some truly obscure biotech names posting massive gains.
From household names like Nvidia to microcaps you’ve never heard of, the market rewarded companies riding the AI boom, clean energy deals, and strategic earnings beats.
Kalshi has a variety of markets where traders are wondering where the numbers might end up — including daily curiosity.
Here’s a breakdown of the biggest stock climbers of the week — and what made investors jump.
Lyra Therapeutics (LYRA)
Up over 400%, Lyra lit up the charts — despite no big news release. A mystery mover like this usually means traders are betting on upcoming trial data, a buyout rumor, or both.
Ctrl Group Limited (MCTR)
Up nearly 385%, this one exploded on sheer volume. No press release, no filings — just a lot of speculation. Could be a meme stock moment or something deeper brewing.
Basel Medical Group (BMGL)
Up 364%. Investors rushed in after whispers of a breakthrough drug trial and renewed licensing talks. Nothing confirmed yet, but biotech bulls are circling.
Prospero Therapeutics (SPRO)
This one’s been volatile all year, but it rocketed 300% after chatter about positive phase 2 results and a potential partner lining up behind the scenes.
K Wave Media (KWMK)
The South Korean media firm jumped nearly 175% after signing new international streaming distribution deals. Global K-content demand is still burning hot.
Nvidia (NVDA)
A modest +2.8% by its standards — but that still pushed Nvidia back to the top of the U.S. market cap rankings. Strong AI chip demand and bullish analyst notes drove the bump.
Broadcom (AVGO)
Climbed 3.3% after launching a next-gen networking chip that’s tailor-made for the AI boom. Investors see it as another pick-and-shovel winner in the data center gold rush.
Dollar General (DG)
Jumped 14% on an earnings beat and a stronger-than-expected outlook. In a tight economy, bargain retailers like DG keep showing muscle.
Constellation Energy (CEG)
Up 12% after landing a 20-year deal to power Meta’s AI data centers with nuclear energy. That’s a long, green bet paying off big.
MoonLake Immunotherapeutics (MLTX)
Gained 33% as investors digested new data from its immunotherapy pipeline and fresh analyst upgrades. Small cap, big upside — if the science holds.
